Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 064385/0345 | |
| Pages: | 10 |
| | Recorded: | 07/26/2023 | | |
| Attorney Dkt #: | 689755-2US |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTYING DATA BY INCLUDING THE 14TH INVENTOR PREVIOUSLY OMITTED PREVIOUSLY RECORDED ON REEL 063827 FRAME 0707. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17767990
|
Filing Dt:
|
04/11/2022
|
|
Publication #:
|
|
Pub Dt:
|
10/26/2023
| | | | |
|
Title:
|
ANTI-CD20 ANTIBODY FORMULATION AND USE OF ANTI-CD20 ANTIBODY FOR TREATMENT OF CD20 POSITIVE DISEASES
|
|
|
Assignee
|
|
|
|
|
| A6-5FL., 11 KAIYUAN RD., SCIENCE CITY |
| HIGH-TECH INDUSTRIAL DEVELOPMENT ZONE |
| GUANGZHOU, GUANGDONG, CHINA 510530 |
|
|
Correspondence name and address
|
| |
PANITCH SCHWARZE BELISARIO & NADEL LLP
|
| |
2001 MARKET STREET, SUITE 2800
|
| |
PHILADELPHIA, PA 19103
|
Search Results as of:
05/23/2024 11:58 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
